Literature DB >> 31323939

Artificial Intelligence Prediction Model for the Cost and Mortality of Renal Replacement Therapy in Aged and Super-Aged Populations in Taiwan.

Shih-Yi Lin1,2, Meng-Hsuen Hsieh3, Cheng-Li Lin4,5, Meng-Ju Hsieh6, Wu-Huei Hsu1,7, Cheng-Chieh Lin1,8, Chung Y Hsu1, Chia-Hung Kao9,10,11.   

Abstract

BACKGROUND: Prognosis of the aged population requiring maintenance dialysis has been reportedly poor. We aimed to develop prediction models for one-year cost and one-year mortality in aged individuals requiring dialysis to assist decision-making for deciding whether aged people should receive dialysis or not.
METHODS: We used data from the National Health Insurance Research Database (NHIRD). We identified patients first enrolled in the NHIRD from 2000-2011 for end-stage renal disease (ESRD) who underwent regular dialysis. A total of 48,153 Patients with ESRD aged ≥65 years with complete age and sex information were included in the ESRD cohort. The total medical cost per patient (measured in US dollars) within one year after ESRD diagnosis was our study's main outcome variable. We were also concerned with mortality as another outcome. In this study, we compared the performance of the random forest prediction model and of the artificial neural network prediction model for predicting patient cost and mortality.
RESULTS: In the cost regression model, the random forest model outperforms the artificial neural network according to the mean squared error and mean absolute error. In the mortality classification model, the receiver operating characteristic (ROC) curves of both models were significantly better than the null hypothesis area of 0.5, and random forest model outperformed the artificial neural network. Random forest model outperforms the artificial neural network models achieved similar performance in the test set across all data.
CONCLUSIONS: Applying artificial intelligence modeling could help to provide reliable information about one-year outcomes following dialysis in the aged and super-aged populations; those with cancer, alcohol-related disease, stroke, chronic obstructive pulmonary disease (COPD), previous hip fracture, osteoporosis, dementia, and previous respiratory failure had higher medical costs and a high mortality rate.

Entities:  

Keywords:  National Health Insurance Research Database (NHIRD); artificial intelligence modeling; dialysis; end-stage renal disease (ESRD)

Year:  2019        PMID: 31323939      PMCID: PMC6678226          DOI: 10.3390/jcm8070995

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

1.  Shared decision-making in advanced kidney disease: a scoping review.

Authors:  Noel Engels; Gretchen N de Graav; Paul van der Nat; Marinus van den Dorpel; Anne M Stiggelbout; Willem Jan Bos
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

2.  Aiding the Diagnosis of Diabetic and Hypertensive Retinopathy Using Artificial Intelligence-Based Semantic Segmentation.

Authors:  Muhammad Arsalan; Muhammad Owais; Tahir Mahmood; Se Woon Cho; Kang Ryoung Park
Journal:  J Clin Med       Date:  2019-09-11       Impact factor: 4.241

Review 3.  Role of Artificial Intelligence in Kidney Disease.

Authors:  Qiongjing Yuan; Haixia Zhang; Tianci Deng; Shumei Tang; Xiangning Yuan; Wenbin Tang; Yanyun Xie; Huipeng Ge; Xiufen Wang; Qiaoling Zhou; Xiangcheng Xiao
Journal:  Int J Med Sci       Date:  2020-04-06       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.